ONC-783
/ OncoC4
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 25, 2024
Legacy OncoC4 Wholly Owned Programs
(GlobeNewswire)
- "ONC-782 – CAR-T cell therapy for solid and hematological malignancies: Initiation of Phase 1 Investigator Initiated Trial in China expected in 2H 2024. ONC-783 – Bispecific mAb for hematological malignancies: IND enabling studies initiated in Q2 2024. ONC-784 – ADC for solid tumors: IND enabling studies to be initiated in Q1 2025."
New P1 trial • Preclinical • Hematological Malignancies • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1